Phillip Frost M.D. et al, Chief Executive Officer and Chairman at Opko Health Inc. (NYSE:OPK) purchased last September 10th through an open market transaction 10,000 shares of Common Stock. These were acquired indirectly at an average weighted price of $8.55, for a total value of $85,540. Following the filing, Mr. Frost directly owns 2,012,377 shares, and indirectly owns 142,943,708 shares held by Frost Gamma Investments Trust, of which he is the trustee, on top of another 15,490,546 shares owned directly by The Frost Group, LLC.
In the same way, Opko Health Inc. (NYSE:OPK)’s major hedge fund shareholder on record have also decided to increase their exposure to the $3.69 billion market cap multi-national biopharmaceutical and diagnostics company. Hal Mintz’s Sabby Capital –owner of over 1.93 million shares- and Israel Englander’s Millennium Management –owner of 218,419 shares- have done so by a 44% and by a 101% respectively. In the meantime, Ken Griffin’s Citadel Investment Group -owner of 180,415 shares- has determined to increase its stake in the firm by a 3681%.
Disclosure: Pamela Gaviño holds no position in any of the stocks or funds mentioned.